search
Back to results

The Effect of Deep Inhalation on Mannitol Responsiveness

Primary Purpose

Asthma

Status
Completed
Phase
Phase 3
Locations
Canada
Study Type
Interventional
Intervention
Deep inhalation technique
Tidal breathing technique
Methacholine
Mannitol
Sponsored by
University of Saskatchewan
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional other trial for Asthma focused on measuring Mannitol, Methacholine, Deep inhalation, Tidal breathing

Eligibility Criteria

18 Years - 75 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • signed informed consent
  • men and women between 18 and 75 years of age
  • FEV1 at first measurement of greater than or equal to 65% predicted
  • methacholine provocative concentration causing a 20% in FEV1 at screening that is less than or equal to 16mg/ml
  • generally good health
  • stable asthma

Exclusion Criteria:

  • respiratory infection within 4 weeks of screening visit
  • worsening of asthma within 4 weeks of screening visit
  • lung disease other than asthma
  • significant medical comorbidity
  • current smoker or ex-smoker with significant smoking history
  • currently pregnant or breastfeeding

Sites / Locations

  • Asthma Research Lab - University of Saskatchewan

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Experimental

Experimental

Experimental

Experimental

Arm Label

Mannitol challenge

Mannitol challenge w/ TBI

Methacholine challenge w/ DI

Methacholine challenge

Arm Description

Mannitol challenge performed per standard mannitol challenge procedure with deep inhalation technique

Mannitol challenge performed per standard mannitol challenge procedure except with tidal breathing technique

Methacholine challenge performed per standard 2-minute tidal breathing challenge procedure except with deep inhalation technique

Methacholine challenge performed per standard 2-minute tidal breathing challenge procedure (tidal breathing technique)

Outcomes

Primary Outcome Measures

Effect of deep inhalation (versus tidal breathing) on mannitol provocative dose causing a 15% fall in forced expiratory volume in one second (FEV1)
Shift in mannitol provocative dose causing a 15% fall in forced expiratory volume

Secondary Outcome Measures

Effect of airway inflammation on methacholine and mannitol challenge results-fractional exhaled nitric oxide
Collection of fractional exhaled nitric oxide at screening - analysis of resulting measurement indicative of degree of baseline airway inflammation
Effect of airway inflammation on methacholine and mannitol challenge results-sputum
Collection of sputum at screening - analysis for differential cell counts indicative of degree of baseline airway inflammation
Effect of deep inhalation (versus tidal breathing) on methacholine provocative
Shift in methacholine provocative dose causing a 20% fall in forced expiratory volume

Full Information

First Posted
March 29, 2018
Last Updated
May 14, 2019
Sponsor
University of Saskatchewan
search

1. Study Identification

Unique Protocol Identification Number
NCT03505489
Brief Title
The Effect of Deep Inhalation on Mannitol Responsiveness
Official Title
The Effect of Deep Inhalation on Mannitol Responsiveness
Study Type
Interventional

2. Study Status

Record Verification Date
May 2019
Overall Recruitment Status
Completed
Study Start Date
June 1, 2018 (Actual)
Primary Completion Date
April 30, 2019 (Actual)
Study Completion Date
April 30, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Saskatchewan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The study will assess how the inhalation technique used (deep inhalations versus tidal breathing) influences the results of a mannitol challenge test and a methacholine challenge test, if at all.
Detailed Description
This study will look at airway responsiveness to inhaled methacholine and mannitol administered with and without deep inhalation. This study will also investigate the role of airway inflammation on these responses, using sputum differential cell counts and fractional exhaled nitric oxide. This is a single center, open label, randomized study. Individuals with stable asthma will be eligible for enrollment. The study will consist of two parts, screening and testing. Part 1: Screening Participants will undergo consent procedures and assessments of fractional exhaled nitric oxide levels, airway responsiveness to methacholine and sputum induction. If participants show airway responsiveness to methacholine (i.e. methacholine PC20 16mg/mL), they will be scheduled to undergo the testing part of the study. Part 2: Testing Participants will be randomized to undergo two methacholine or two mannitol challenges. Further randomization will occur with respect to whether the standard challenge method or the modified challenge method is performed first.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Asthma
Keywords
Mannitol, Methacholine, Deep inhalation, Tidal breathing

7. Study Design

Primary Purpose
Other
Study Phase
Phase 3
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
26 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Mannitol challenge
Arm Type
Experimental
Arm Description
Mannitol challenge performed per standard mannitol challenge procedure with deep inhalation technique
Arm Title
Mannitol challenge w/ TBI
Arm Type
Experimental
Arm Description
Mannitol challenge performed per standard mannitol challenge procedure except with tidal breathing technique
Arm Title
Methacholine challenge w/ DI
Arm Type
Experimental
Arm Description
Methacholine challenge performed per standard 2-minute tidal breathing challenge procedure except with deep inhalation technique
Arm Title
Methacholine challenge
Arm Type
Experimental
Arm Description
Methacholine challenge performed per standard 2-minute tidal breathing challenge procedure (tidal breathing technique)
Intervention Type
Procedure
Intervention Name(s)
Deep inhalation technique
Intervention Description
Use of deep inhalations for administration of inhalant
Intervention Type
Procedure
Intervention Name(s)
Tidal breathing technique
Intervention Description
Use of tidal breathing for administration of inhalant
Intervention Type
Drug
Intervention Name(s)
Methacholine
Other Intervention Name(s)
Provocholine
Intervention Description
Methacholine direct bronchoconstrictor used for bronchoprovocation challenge
Intervention Type
Drug
Intervention Name(s)
Mannitol
Other Intervention Name(s)
Aridol
Intervention Description
Mannitol indirect bronchoconstrictor used for bronchoprovocation challenge
Primary Outcome Measure Information:
Title
Effect of deep inhalation (versus tidal breathing) on mannitol provocative dose causing a 15% fall in forced expiratory volume in one second (FEV1)
Description
Shift in mannitol provocative dose causing a 15% fall in forced expiratory volume
Time Frame
24 hours between mannitol challenges
Secondary Outcome Measure Information:
Title
Effect of airway inflammation on methacholine and mannitol challenge results-fractional exhaled nitric oxide
Description
Collection of fractional exhaled nitric oxide at screening - analysis of resulting measurement indicative of degree of baseline airway inflammation
Time Frame
up to 2 weeks, from baseline to end of study
Title
Effect of airway inflammation on methacholine and mannitol challenge results-sputum
Description
Collection of sputum at screening - analysis for differential cell counts indicative of degree of baseline airway inflammation
Time Frame
up to 2 weeks, from baseline to end of study
Title
Effect of deep inhalation (versus tidal breathing) on methacholine provocative
Description
Shift in methacholine provocative dose causing a 20% fall in forced expiratory volume
Time Frame
24 hours between methacholine challenges

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: signed informed consent men and women between 18 and 75 years of age FEV1 at first measurement of greater than or equal to 65% predicted methacholine provocative concentration causing a 20% in FEV1 at screening that is less than or equal to 16mg/ml generally good health stable asthma Exclusion Criteria: respiratory infection within 4 weeks of screening visit worsening of asthma within 4 weeks of screening visit lung disease other than asthma significant medical comorbidity current smoker or ex-smoker with significant smoking history currently pregnant or breastfeeding
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Dr. Don Cockcroft, MD
Organizational Affiliation
University of Saskatchewan
Official's Role
Principal Investigator
Facility Information:
Facility Name
Asthma Research Lab - University of Saskatchewan
City
Saskatoon
State/Province
Saskatchewan
ZIP/Postal Code
S7N 0W8
Country
Canada

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
31785175
Citation
Blais CM, Davis BE, Cockcroft DW. The effect of deep inhalation on mannitol responsiveness. Clin Exp Allergy. 2020 Mar;50(3):308-314. doi: 10.1111/cea.13543. Epub 2019 Dec 14.
Results Reference
derived
PubMed Identifier
31542451
Citation
Blais CM, Davis BE, Graham BL, Cockcroft DW. Respiratory Duty Cycles in Individuals With and Without Airway Hyperresponsiveness. Chest. 2020 Feb;157(2):356-362. doi: 10.1016/j.chest.2019.09.005. Epub 2019 Sep 19.
Results Reference
derived

Learn more about this trial

The Effect of Deep Inhalation on Mannitol Responsiveness

We'll reach out to this number within 24 hrs